Hepatocellular carcinoma
Conditions
Interventions
Sponsors
Department of General Surgery, Tangdu Hospital, Air Force Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: This study included patients who were diagnosed with HCC according to the American Association for the Study of the Liver Disease/European Association for the Study of the Liver Guidelines and who received conventional LR or TACE.
Exclusion criteria
Exclusion criteria: Patients were excluded if at least one of the following pre-defined criteria was met: (1) presence of types III/IV portal vein tumour thrombosis (PVTT), hepatic artery, biliary duct or inferior vena cava invasion; (2) presence of extrahepatic spread (EHS); (3) underwent previous treatments; (4) Eastern Cooperative Oncology Group Performance Status (ECOG-PS) >1; (5) diffuse tumor nodules; (6) combined with other tumours or severe cardiac, cerebral, and renal insufficiency; (7) non-CSPH, and (8) absence of baseline information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality; | — |
Countries
China
Contacts
Public ContactLei Liu
Air Force Medical University
Outcome results
None listed